You appear to be offline. Some data may be unavailable until your connection is restored.
VTRS
StockViatris Inc
Price data not available
Description
Viatris Inc. is a global pharmaceutical company that develops, manufactures and markets a broad range of prescription medicines, including generic drugs, off‑patent branded products, biosimilars and selected specialty assets. The firm was created in 2020 through the merger of Mylan and Pfizer’s Upjohn business, combining Mylan’s extensive generics platform with Upjohn’s legacy branded portfolio and worldwide distribution network. Operating in the healthcare and pharmaceuticals sector, Viatris serves more than 165 countries and holds a portfolio of over 1,400 approved molecules, positioning it as one of the largest providers of affordable, established‑medicine treatments worldwide. Notable aspects of its strategy include expanding access to medicines, leveraging a global supply chain, and pursuing selective acquisitions to strengthen specialty and ophthalmology capabilities.
DividendAnnual yield: Percentage of stock price paid annually as dividends.Frequency: How often dividends are paid out (e.g. monthly, quarterly, semi-annual, or annual).Ex-dividend date: Purchase before this date to be eligible for the dividend payment.Payment date: When dividend payments are distributed.Payout: Dividend amount paid per share.Dates marked (est.) are projected from past dividend history.
Dividend history
| Amount | Ex-Date | Payment Date |
|---|---|---|
| $0.12 | Nov 23, 2026 | Dec 16, 2026 |
| $0.12 | Aug 21, 2026 | Sep 16, 2026 |
| $0.12 | May 22, 2026 | Jun 17, 2026 |
Track every VTRS dividend
Get reminders ahead of VTRS's ex-dividend and payment dates, so you always know when distributions are coming. Pair them with price and earnings alerts to keep your full income picture in view.